|
|
| DIA 2024 | DIA 2024 invites industry, regulators, governments, academics, innovators, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in San Diego, DIA 2024 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being. |
|
|
|
| Fortifying The 3 Cs With Strategic Approaches And Tools | Guest Column | By Richard Malone, PharmD, MHA, Tanisha Patel, Vincent Puglia, and Renee Riggs | In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration. |
|
|
|
| Human Abuse Potential | Brochure | Altasciences | With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics. |
|
|
|
|
| What To Expect From An FDA Inspection | From The Editor | By Dan Schell, chief editor, Clinical Leader | Former FDA inspector turned regulatory consultant, Patrick Stone, gives some valuable insights into what to expect when the FDA comes knocking at the door of your clinical trial site. |
|
|
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|